NDC product
SODIUM POLYSTYRENE SULFONATE
NDC 11534-166 · SUNRISE PHARMACEUTICAL, INC.
Key facts
| Product NDC | 11534-166 |
|---|---|
| Proprietary name | SODIUM POLYSTYRENE SULFONATE |
| Nonproprietary name | sodium polystyrene sulfonate |
| Substances | SODIUM POLYSTYRENE SULFONATE |
| Dosage form | POWDER, FOR SUSPENSION |
| Route | ORAL, RECTAL |
| Labeler | SUNRISE PHARMACEUTICAL, INC. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA204071 |
| Marketing start | Jan 24, 2017 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: